CVS Group plc Exercise of Options & TVR - Replacement (5741Z)
16 March 2017 - 12:39AM
UK Regulatory
TIDMCVSG
RNS Number : 5741Z
CVS Group plc
15 March 2017
This announcement replaces the 'Exercise of Options and TVR'
announcement released on 14 March 2017 at 17:29 under RNS No
4752Z.
The announcement has been amended to reflect issuance of 669
Ordinary Shares not included in the figure of 24,859 from 6 March
2017.
There are no other material changes and the full amended text is
shown below:
15 March 2017
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading provider of integrated veterinary
services for small and large animals, announces that 24,859
ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE
Shares") were issued on 6 March 2017 as a result of the exercise of
employee share options, in connection with the Company's December
2013 - December 2016 Save As You Earn (SAYE) Scheme. A further 669
Ordinary Shares were issued on 14 March 2017 in connection with the
exercise of options by a former employee under this SAYE
Scheme.
The SAYE Shares rank pari passu with all existing Ordinary
Shares. The admission of the SAYE Shares has been satisfied via the
Company's block listing which was announced on 19 December 2016
(the "Block Listing").
The Company also announces that 965 Ordinary Shares (the "New
Shares") were issued on 14 March 2017 as a result of the exercise
of employee share options by the same former employee, in
connection with the Company's December 2014 - December 2017 and
December 2015 - December 2018 SAYE Schemes. Application has been
made for the New Shares, which rank pari passu in all respects with
the Company's existing Ordinary Shares, to be admitted to trading
on AIM which is expected to occur on or around 20 March 2017.
Following issue of the New Shares and the SAYE Shares, the
Company's total issued share capital will consist of 63,878,575
Ordinary Shares with one voting right per share. The Company does
not hold any Ordinary Shares in Treasury. Therefore, following the
issue of the New Shares, the total number of voting rights in the
Company is 63,878,575 This figure may be used by shareholders as
the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change to
their interest in, the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Contacts:
CVS Group plc Tel: 01379 644
Simon Innes, Chief Executive 288
Nick Perrin, Finance Director
N+1 Singer (Nominated Adviser Tel: 020 7496
& Broker) 3000
Aubrey Powell
Liz Yong
James Hopton
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEOKPDNNBKDPND
(END) Dow Jones Newswires
March 15, 2017 09:39 ET (13:39 GMT)
Cvs (LSE:CVSG)
Historical Stock Chart
From Apr 2024 to May 2024
Cvs (LSE:CVSG)
Historical Stock Chart
From May 2023 to May 2024